Drug development for stroke: importance of protecting cerebral white matter

By Dewar D.   Yam P.   McCulloch J.  

European Journal of Pharmacology, Vol. 375, Iss. 1, 1999-06 ,pp. : 41-50

Elsevier

Access to resources Recommend Favorite

Cerebral White Matter Injuries Following a Hypoxic/Ischemic Insult During the Perinatal Period: Pathophysiology, Prognostic Factors, and Future Strategy of Treatment Approach. A Minireview

By  

Current Pharmaceutical Design, Vol. 21, Iss. 11, 2015-02 ,pp. : 1418-1425

Bentham Science Publishers

Access to resources Recommend Favorite

Cerebral Aneurysm as an Exacerbating Factor in Stroke Pathology and a Therapeutic Target for Neuroprotection

By  

Current Pharmaceutical Design, Vol. 18, Iss. 25, 2012-07 ,pp. : 3663-3669

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroprotection by Methylene Blue in Cerebral Global Ischemic Injury Induced Blood-Brain Barrier Disruption and Brain Pathology: A Review

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 9, 2016-11 ,pp. : 1181-1187

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic issue: Critical Appraisal of Ischemic Stroke Pathophysiology: Road to Cerebral Resuscitation? Part II)

By  

Current Medicinal Chemistry, Vol. 21, Iss. 19, 2014-06 ,pp. : 2119-2120

Bentham Science Publishers

Access to resources Recommend Favorite